IMVT
Immunovant, Inc. · Healthcare
Chief Financial Officer Tiago Girao sold $385K of Immunovant, Inc.
Sold$384,600
$38.46Price
10,000Shares
−4%Stake
What IMVT did after the filing
- The stock from Mon, Jun 29 open, $38.29
- +6.9%
- S&P 500, same days
- +4.6%
Measured over 30 trading days, to the Aug 11 close.
Traded Fri, Jun 26. Filed Fri, Jun 26, 7:44 PM ET, after the close. Returns use the Jun 29 open and the Aug 11 close. Not investment advice.